X-linked lymphoproliferative syndrome.
Nelson DL, Terhorst C.
Clin Exp Immunol. 2000 Dec;122(3):291-5. doi: 10.1046/j.1365-2249.2000.01400.x.
X-linked lymphoproliferative syndrome.
Sullivan JL, Woda BA.
Immunodefic Rev. 1989;1(4):325-47.
X-linked lymphoproliferative disease.
Seemayer TA, Grierson H, Pirruccello SJ, Gross TG, Weisenburger DD, Davis J, Spiegel K, Brichacek B, Sumegi J.
Am J Dis Child. 1993 Nov;147(11):1242-5. doi: 10.1001/archpedi.1993.02160350116018.
Post-Transplantation Lymphoproliferative Disorders in Adults.
Dierickx D, Habermann TM.
N Engl J Med. 2018 Feb 8;378(6):549-562. doi: 10.1056/NEJMra1702693.
X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma.
Rezaei N, Mahmoudi E, Aghamohammadi A, Das R, Nichols KE.
Br J Haematol. 2011 Jan;152(1):13-30. doi: 10.1111/j.1365-2141.2010.08442.x. Epub 2010 Nov 18.
[X-linked lymphoproliferative syndrome].
Kanegane H.
Nihon Rinsho Meneki Gakkai Kaishi. 2002 Feb;25(1):129-34.
Natural killer T cells and X-linked lymphoproliferative syndrome.
Latour S.
Curr Opin Allergy Clin Immunol. 2007 Dec;7(6):510-4. doi: 10.1097/ACI.0b013e3282f1bad6.
Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
Suzuki T, Sato Y, Okuno Y, Torii Y, Fukuda Y, Haruta K, Yamaguchi M, Kawamura Y, Hama A, Narita A, Muramatsu H, Yoshikawa T, Takahashi Y, Kimura H, Ito Y, Kawada JI.
J Clin Immunol. 2024 Apr 20;44(4):103. doi: 10.1007/s10875-024-01701-0.
The abnormal gene in X-linked lymphoproliferative syndrome.
Sullivan JL.
Curr Opin Immunol. 1999 Aug;11(4):431-4. doi: 10.1016/S0952-7915(99)80072-7.
X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.
Aguilar C, Latour S.
J Clin Immunol. 2015 May;35(4):331-8. doi: 10.1007/s10875-015-0141-9. Epub 2015 Mar 4.
